/7096.T
7096.T Stock - StemCell Institute Inc.
Healthcare|BiotechnologyJPX
$758.00-0.26%
$2.00 (-0.26%) • Dec 24
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.10
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $833.80
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 7096.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$750.42 – $765.58
TARGET (TP)$871.70
STOP LOSS$697.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.52
52W High$1543.00
52W Low$744.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.68B | $2.48B | $2.09B | $1.78B | $1.41B |
| Gross Profit | $1.69B | $1.58B | $1.34B | $1.11B | $924.21M |
| Gross Margin | 63.2% | 63.5% | 63.9% | 62.4% | 65.6% |
| Operating Income | $418.51M | $413.76M | $297.56M | $226.95M | $86.88M |
| Net Income | $385.80M | $310.98M | $198.03M | $133.73M | $62.37M |
| Net Margin | 14.4% | 12.5% | 9.5% | 7.5% | 4.4% |
| EPS | $37.67 | $30.25 | $19.33 | $13.20 | $6.41 |
Company Overview
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
7096.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$4.24
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | — | — | — |
Q3 2025 | Aug 7, 2025 | — | $4.24 | — | — |
Q2 2025 | May 13, 2025 | — | $4.48 | — | — |
Q1 2025 | Feb 13, 2025 | — | $6.64 | — | — |
Q4 2024 | Nov 12, 2024 | — | $9.08 | — | — |
Q3 2024 | Aug 7, 2024 | — | $17.37 | — | — |
Q2 2024 | May 14, 2024 | — | $5.47 | — | — |
Q1 2024 | Feb 7, 2024 | — | $9.29 | — | — |
Q4 2023 | Nov 8, 2023 | — | $8.21 | — | — |
Q2 2023 | Jun 30, 2023 | — | $7.39 | — | — |
Q2 2023 | May 11, 2023 | — | $1.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $6.07 | — | — |
Q4 2022 | Nov 8, 2022 | — | $5.81 | — | — |
Q3 2022 | Sep 30, 2022 | — | $5.81 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 7096.T
What is 7096.T's current stock price?
StemCell Institute Inc. (7096.T) is currently trading at $758.00 per share. The stock has moved -0.26% today.
What is the analyst price target for 7096.T?
No analyst price targets are currently available for this stock.
What sector is StemCell Institute Inc. in?
StemCell Institute Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 7096.T's market cap?
StemCell Institute Inc. has a market capitalization of $7.72 billion, making it a mid-cap company.
Does 7096.T pay dividends?
No, StemCell Institute Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector177A.T
Kohjin Bio Co., Ltd.
$1461.00
Mkt Cap: $7.5B
2183.T
Linical Co., Ltd.
$293.00
Mkt Cap: $6.6B
2370.T
MEDINET Co., Ltd.
$28.00
Mkt Cap: $7.4B
3750.T
ADR120S, Inc.
$825.00
Mkt Cap: $7.4B
4564.T
OncoTherapy Science, Inc.
$21.00
Mkt Cap: $7.1B
4583.T
Chiome Bioscience Inc.
$108.00
Mkt Cap: $7.3B
4594.T
BrightPath Biotherapeutics Co., Ltd.
$46.00
Mkt Cap: $4.3B
4893.T
Noile-Immune Biotech Inc.
$133.00
Mkt Cap: $5.8B
4896.T
K Pharma,Inc.
$638.00
Mkt Cap: $7.4B
9218.T
Mental Health Technologies Co.,Ltd.
$865.00
Mkt Cap: $9.0B
Explore stocks similar to 7096.T for comparison